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Letters to the Editor
Misidentiﬁcation  of  pan  drug-resistant  Klebsiella
pneumoniae clinical  isolates  as a
metallo--lactamase producers  by the  EDTA/DDST
test
Dear Editor,
Carbapenemase-producing Enterobacteriaceae may  exhibit
susceptibility to carbapenems. For this reason with the recent
spread  of NDM-1 among Enterobacteriaceae, the phenotypic
detection of metallo-beta-lactamase (ML)-producing has
been  recommended by Brazilian Agency of Sanitary Surveil-
lance  (ANVISA).1
In 2013, two pan drug-resistant Klebsiella pneumoniae (KPN1
and  KPN2) isolates were  recovered from urine (cystostomy) of
a  75-year-old male patient hospitalized in a tertiary teach-
ing  hospital in Florianópolis, Santa Catarina, Brazil. Both
isolates  were  phenotypically identiﬁed as ML producers by
ethylenediamine tetraacetic acid (EDTA)/double-disk synergy
test  (DDST) and forwarded to our laboratory for further charac-
terization.  Identiﬁcation of both isolates as K. pneumoniae was
conﬁrmed  by MALDI-TOF MS  (Bruker Daltonics, Germany),
according to the manufacturer’s recommendations. Both iso-
lates showed an identical pattern by ERIC-PCR. The minimal
inhibitory  concentrations (MICs) for selected antimicrobial
agents were  determined by broth microdilution according to
Clinical and Laboratory Standards Institute – CLSI. The MICs
were  interpreted according to the CLSI guidelines,2 except
for  tigecycline, which interpretation was  performed according
to  the European Committee on Antimicrobial Susceptibility
Testing – EUCAST. Both isolates were fully resistant to all
broad-spectrum cephalosporins, aztreonam, gentamicin, ﬂu-
oroquinolones, meropenem, ertapenem, and polymyxin B as
shown in Table 1. The isolates showed intermediate resistance
to  imipenem and amikacin. While KPN1 was  susceptible to
tigecycline,  KPN2 became resistant to this agent.
The isolates were  also screened for ESL production by disk
approximation and the synergism was  observed only when
amoxicillin/clavulanic acid disk was  tested 15 mm a part of
ceftriaxone,  ceftazidime and cefepime disks. The phenotypic
detection of ML was  carried out by the EDTA/DDST and con-
ﬁrmed  by ertapenem hydrolysis assay using MALDI-TOF MS(Bruker  Daltonics, Germany) as previously reported.3 Although
both  isolates showed an increase in the inhibition zone of
ceftazidime/EDTA (6 mm)  and meropenem/EDTA (7 mm)  disks
compared  to the ceftazidime and meropenem disks, respec-
tively,  hydrolysis of ertapenem was  not observed, suggesting
that  both isolates were not ML producers.
The search for -lactamase encoding genes was  carried
out  by PCR followed by DNA sequencing of amplicons. Both
K.  pneumoniae isolates carried blaCTX-M-15, and the narrow
spectrum--lactamases encoding genes, blaSHV-11, blaTEM-1
and blaOXA-1. The presence of the plasmid mediated qnrS1 gene
and  a mutation Ser83Ile in gyrA were also detected, justifying
the  quinolone resistance exhibited by both KPN isolates. The
analysis  of the outer membrane proteins proﬁle by SDS–PAGE
showed  that both isolates lost the major porins OmpK35 and
OmpK36.  Sequencing analysis of the ompk35 and ompk36 genes
revealed  the presence of the insertion sequence IS1 between
the  promoter region and the start codon of the ompK35 gene,
and  the presence of the IS908 disrupting the ompK36 gene.
These  results corroborated with the absence of the major
porins  on the SDS–PAGE gels, since the presence of the IS
resulted  in non-functional OmpK35 and OmpK36 porins.
The  misidentiﬁcation of two pan-resistant K. pneumoniae
isolates as ML producers by the EDTA/DDST is in agreement
with  previous study that reported false-positive results when
EDTA  was  employed for identiﬁcation of the ML production.4
This fact may  result from the bactericidal effect of EDTA which
acts  increasing the membrane permeability.5 Based on that, a
disk contained only 100 mM of EDTA was also tested in the
present  study, conﬁrming their bactericidal effect, since con-
siderable  inhibition diameter zones of 18 mm for KPN1 and
16  mm for KPN2 were  observed.
This study reported a misidentiﬁcation of ML producers
by  EDTA/DDST in K. pneumoniae clinical isolates, as recom-
mended  by ANVISA.1 The pan-resistant phenotype observed
between  the two K. pneumoniae strains isolated in our ter-
ritory  is worrisome, since very few therapeutic options are
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Table 1 – Antimicrobial susceptibility proﬁle and resistant determinants among the K. pneumoniae isolates misidentiﬁed as ML producers by EDTA/DDST.
Isolate MALDI-TOF
MS ID
MIC  (g/mL)/susceptibility categorya
CEP CAZ CTX FEP AZT IPM MEM ETP AK GEN LEV CIP TGC PO
KPN 1 K. pneumoniae ≥256[R] ≥256[R] ≥256[R] ≥256[R] ≥32[R] 2[I] 8[R] 64[R] 32[I] ≥64[R] ≥128[R] ≥128[R] 1[S] 32[R]
KPN 2 K. pneumoniae ≥256[R] ≥256[R] ≥256[R] ≥256[R] ≥32[R] 2[I] 8[R] 64[R] 32[I] ≥64[R] ≥128[R] ≥128[R] 4[R] 32[R]
Isolate MALDI-TOF MS ID Diameter variation with EDTA (mm) Porin lesion typeb Resistant determinants
CAZ MEM OmpK 35 OmpK36
KPN 1 K. pneumoniae 7 6 IS1(−5) IS908(+726) CTX-M-15, TEM-1, SHV-11, QnrS1, OXA-1
KPN 2 K. pneumoniae 7 6 IS1(−5) IS908(+726) CTX-M-15, TEM-1, SHV-11, QnrS1, OXA-1
a Abbreviations: CEP, cephalotin; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; IPM, imipenem; MEM, meropenem; ETP, ertapenem; AK, amikacin; GEN, gentamicin; LEV, levoﬂoxacin; CIP,
ciproﬂoxacin; TGC, tigecyclin; PO, polymyxin B.
b Porin lesion type: + and − indicate the position upstream and downstream of start codon; numbers between parentheses correspond the nucleotide insertion position; ISn indicate the mutation
in the promoter region and presence of insertion sequences, respectively.
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clinically available for treating such infections. Probably, the
isolates  also possess other resistance mechanisms that had
contributed  to their multi-drug resistant proﬁle. The chelating
agents  such as EDTA can increase the outer membrane perme-
ability,  facilitating the entry of antibiotics.4,5 Based on that,
disk  contained only 100 mM of EDTA should be used addition-
ally,  to conﬁrm their bactericidal effect; therefore attention
should  be taken by the routine laboratories to avoid the report
of  false positive results.
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